Author: Kathy Whitney
Oct. 15, 2015—Ashish Shah, M.D., has joined Vanderbilt Heart and Vascular Institute (VHVI) as director of Heart Transplant and Mechanical Circulatory Support.
Oct. 15, 2015—Vanderbilt University Medical Center is hosting the first Global Cardio-Oncology Summit on Oct. 15-16, at the Hilton Nashville. The summit models a leading edge, interdisciplinary approach to cardio-oncology.
Oct. 8, 2015—The first study to suggest that major depressive disorder (MDD) is an independent risk factor for heart failure in HIV-positive adults has been published in Circulation.
Sep. 24, 2015—Vanderbilt is embarking on a multi-disciplinary approach to understand how promising cancer treatments, specifically certain kinase inhibitors, affect the heart and kidneys.
Sep. 17, 2015—The initial results of a landmark clinical trial sponsored by the National Institutes of Health (NIH) indicate lowering systolic blood pressure below a commonly recommended target significantly reduces rates of cardiovascular events and lowers risk of death in a group of adults 50 years and older.
Sep. 17, 2015—In April 1986 Bonnie Davis of Mt. Pleasant, Tennessee, became the first female patient to receive a heart transplant at Vanderbilt University Hospital. On Oct. 3, she will return to campus to participate in the Greater Nashville Heart Walk.
Sep. 10, 2015—Joshua Beckman, M.D., MSc., previously a faculty member at Harvard Medical School and Brigham and Women’s Hospital, has been named director of Vanderbilt’s newly formed Section of Vascular Medicine within the Division of Cardiovascular Medicine.
Aug. 13, 2015—A team of Vanderbilt and Nashville VA researchers, led by Adriana Hung, M.D., MPH, has been awarded a grant from the U.S. Department of Veterans Affairs to use the Million Veteran Program (MVP) data to conduct diabetes research.
Jun. 17, 2015—Vanderbilt Heart and Vascular Institute now offers patients with atrial fibrillation (AF) an alternative treatment to reduce their risk of stroke, potentially avoiding the long-term use of blood thinners such as warfarin.